In neuroblastoma, KDM6B is upregulated by retinoic acid via HOXC9 to remove the repressive chromatin marker H3K27me3 and induce neuronal differentiation, thus inhibiting cell proliferation and tumorigenicity (Yang et al., 2019). Here, KDM6B is linked to neuroblastoma.